nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—SLC22A11—Furosemide—dilated cardiomyopathy	0.307	0.503	CbGbCtD
Minocycline—SLC22A8—Furosemide—dilated cardiomyopathy	0.179	0.293	CbGbCtD
Minocycline—SLC22A6—Furosemide—dilated cardiomyopathy	0.124	0.204	CbGbCtD
Minocycline—CYCS—myocardium—dilated cardiomyopathy	0.00775	0.105	CbGeAlD
Minocycline—CASP3—cardiac ventricle—dilated cardiomyopathy	0.00706	0.0959	CbGeAlD
Minocycline—CASP3—myocardium—dilated cardiomyopathy	0.00664	0.0902	CbGeAlD
Minocycline—CASP1—heart—dilated cardiomyopathy	0.00562	0.0764	CbGeAlD
Minocycline—VEGFA—cardiac ventricle—dilated cardiomyopathy	0.00555	0.0754	CbGeAlD
Minocycline—CYCS—heart—dilated cardiomyopathy	0.00541	0.0735	CbGeAlD
Minocycline—IL1B—myocardium—dilated cardiomyopathy	0.0053	0.0721	CbGeAlD
Minocycline—VEGFA—Enalapril—Lisinopril—dilated cardiomyopathy	0.00527	1	CbGdCrCtD
Minocycline—VEGFA—myocardium—dilated cardiomyopathy	0.00522	0.0709	CbGeAlD
Minocycline—CASP3—heart—dilated cardiomyopathy	0.00463	0.063	CbGeAlD
Minocycline—MMP9—myocardium—dilated cardiomyopathy	0.00442	0.0601	CbGeAlD
Minocycline—IL1B—heart—dilated cardiomyopathy	0.0037	0.0503	CbGeAlD
Minocycline—VEGFA—heart—dilated cardiomyopathy	0.00364	0.0495	CbGeAlD
Minocycline—VEGFA—cardiac atrium—dilated cardiomyopathy	0.00311	0.0423	CbGeAlD
Minocycline—MMP9—heart—dilated cardiomyopathy	0.00309	0.0419	CbGeAlD
Minocycline—ALOX5—heart—dilated cardiomyopathy	0.00244	0.0331	CbGeAlD
Minocycline—IL1B—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.00035	0.00112	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SCN5A—dilated cardiomyopathy	0.000349	0.00112	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000349	0.00112	CbGpPWpGaD
Minocycline—MMP9—Matrix Metalloproteinases—TNF—dilated cardiomyopathy	0.000347	0.00112	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.000347	0.00111	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—FASLG—dilated cardiomyopathy	0.00034	0.00109	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000338	0.00109	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—CD36—dilated cardiomyopathy	0.000337	0.00108	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.000333	0.00107	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000333	0.00107	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—TNF—dilated cardiomyopathy	0.00033	0.00106	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00033	0.00106	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000329	0.00106	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—FASLG—dilated cardiomyopathy	0.000329	0.00106	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000328	0.00105	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—FAS—dilated cardiomyopathy	0.000327	0.00105	CbGpPWpGaD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000322	0.00103	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—RAC1—dilated cardiomyopathy	0.000322	0.00103	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000321	0.00103	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000318	0.00102	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TNF—dilated cardiomyopathy	0.000318	0.00102	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000317	0.00102	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—FAS—dilated cardiomyopathy	0.000317	0.00102	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.000313	0.00101	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.000313	0.00101	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—EGFR—dilated cardiomyopathy	0.000309	0.000992	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—FASLG—dilated cardiomyopathy	0.000308	0.000991	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—RAC1—dilated cardiomyopathy	0.000307	0.000986	CbGpPWpGaD
Minocycline—CASP3—Caspase Cascade in Apoptosis—TNF—dilated cardiomyopathy	0.0003	0.000963	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—FAS—dilated cardiomyopathy	0.000297	0.000955	CbGpPWpGaD
Minocycline—IL1B—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000296	0.000953	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—RAC1—dilated cardiomyopathy	0.000291	0.000936	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000288	0.000926	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.000287	0.000923	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.000287	0.000921	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000286	0.000919	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ANKRD1—dilated cardiomyopathy	0.000286	0.000919	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	0.000283	0.00091	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.00028	0.000899	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.00028	0.000899	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—RAC1—dilated cardiomyopathy	0.000279	0.000898	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—FASLG—dilated cardiomyopathy	0.000279	0.000897	CbGpPWpGaD
Minocycline—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—dilated cardiomyopathy	0.000279	0.000896	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000278	0.000894	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000275	0.000883	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.000274	0.000881	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—RAF1—dilated cardiomyopathy	0.000273	0.000876	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—dilated cardiomyopathy	0.000272	0.000875	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—FAS—dilated cardiomyopathy	0.000269	0.000864	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TAZ—dilated cardiomyopathy	0.000269	0.000864	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000268	0.000862	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000268	0.000862	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—TNF—dilated cardiomyopathy	0.000265	0.000853	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—RAC1—dilated cardiomyopathy	0.000264	0.000848	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000263	0.000845	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—RAF1—dilated cardiomyopathy	0.000255	0.000819	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.000252	0.000811	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—RAC1—dilated cardiomyopathy	0.000252	0.00081	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by TCPTP—EGFR—dilated cardiomyopathy	0.000252	0.000809	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—RAF1—dilated cardiomyopathy	0.000249	0.0008	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—RAF1—dilated cardiomyopathy	0.000249	0.0008	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000244	0.000786	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TTN—dilated cardiomyopathy	0.000244	0.000785	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SDHA—dilated cardiomyopathy	0.000243	0.000781	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TNF—dilated cardiomyopathy	0.000241	0.000775	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—RAF1—dilated cardiomyopathy	0.00024	0.000771	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—PSEN2—dilated cardiomyopathy	0.000238	0.000764	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—RAC1—dilated cardiomyopathy	0.000238	0.000764	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—RAC1—dilated cardiomyopathy	0.000233	0.000748	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000231	0.000742	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—TNF—dilated cardiomyopathy	0.000231	0.000742	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000226	0.000725	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000225	0.000723	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—EGFR—dilated cardiomyopathy	0.000222	0.000713	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—dilated cardiomyopathy	0.00022	0.000706	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000219	0.000705	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000219	0.000705	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000218	0.000702	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000214	0.000689	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000212	0.000681	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ACTN2—dilated cardiomyopathy	0.000212	0.000681	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TNF—dilated cardiomyopathy	0.000209	0.000671	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000209	0.000671	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—PSEN2—dilated cardiomyopathy	0.000206	0.000664	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000205	0.000658	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—TNF—dilated cardiomyopathy	0.000204	0.000656	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000204	0.000656	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000199	0.00064	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000199	0.00064	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.000199	0.00064	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—ITGB1—dilated cardiomyopathy	0.000198	0.000636	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.000194	0.000624	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.000193	0.000621	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	0.000192	0.000617	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000192	0.000616	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000191	0.000615	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—RAC1—dilated cardiomyopathy	0.00019	0.000612	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—EGFR—dilated cardiomyopathy	0.000187	0.000601	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	0.000186	0.000598	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000185	0.000595	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	0.000183	0.000587	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—VCL—dilated cardiomyopathy	0.00018	0.000579	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000176	0.000566	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000176	0.000565	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.000175	0.000563	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.000175	0.000562	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000174	0.00056	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000172	0.000553	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TNF—dilated cardiomyopathy	0.00017	0.000547	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00017	0.000545	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000168	0.000539	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000167	0.000538	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000167	0.000538	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000167	0.000538	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—RAF1—dilated cardiomyopathy	0.000167	0.000537	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD36—dilated cardiomyopathy	0.000167	0.000536	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—dilated cardiomyopathy	0.000167	0.000536	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TAZ—dilated cardiomyopathy	0.000166	0.000532	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000162	0.000519	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000162	0.000519	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—RAC1—dilated cardiomyopathy	0.000159	0.000511	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000159	0.000511	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000158	0.000509	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—RAF1—dilated cardiomyopathy	0.000158	0.000507	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—RAC1—dilated cardiomyopathy	0.000157	0.000505	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000156	0.0005	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.000154	0.000496	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000151	0.000487	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SDHA—dilated cardiomyopathy	0.00015	0.000481	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00015	0.000481	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—ITGB1—dilated cardiomyopathy	0.000149	0.000478	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000147	0.000474	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.000144	0.000464	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000144	0.000461	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000141	0.000453	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.00014	0.000449	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00014	0.000449	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00014	0.000449	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—dilated cardiomyopathy	0.000139	0.000447	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—dilated cardiomyopathy	0.000135	0.000432	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000134	0.00043	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.000133	0.000428	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—dilated cardiomyopathy	0.000133	0.000427	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	0.000132	0.000426	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00013	0.000417	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—ITGB1—dilated cardiomyopathy	0.000129	0.000415	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000126	0.000406	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	0.000126	0.000405	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000122	0.000392	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000121	0.000389	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	0.00012	0.000385	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—RAC1—dilated cardiomyopathy	0.00012	0.000384	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.00012	0.000384	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	0.000116	0.000373	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000116	0.000373	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	0.000114	0.000367	CbGpPWpGaD
Minocycline—CASP1—Immune System—ITGB1—dilated cardiomyopathy	0.000114	0.000366	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000114	0.000366	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000106	0.000341	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000106	0.00034	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—RAF1—dilated cardiomyopathy	0.000105	0.000339	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000105	0.000338	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—RAF1—dilated cardiomyopathy	0.000104	0.000335	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—RAC1—dilated cardiomyopathy	0.000104	0.000334	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD36—dilated cardiomyopathy	9.72e-05	0.000312	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	9.35e-05	0.0003	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ITGB1—dilated cardiomyopathy	9.21e-05	0.000296	CbGpPWpGaD
Minocycline—CASP1—Immune System—RAC1—dilated cardiomyopathy	9.16e-05	0.000294	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.13e-05	0.000294	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CD36—dilated cardiomyopathy	9.05e-05	0.000291	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—ITGB1—dilated cardiomyopathy	9.04e-05	0.000291	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.9e-05	0.000286	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	8.69e-05	0.000279	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—EGFR—dilated cardiomyopathy	8.65e-05	0.000278	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.58e-05	0.000276	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—RAC1—dilated cardiomyopathy	8.53e-05	0.000274	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.13e-05	0.000261	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	8.07e-05	0.000259	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.01e-05	0.000257	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—RAF1—dilated cardiomyopathy	7.93e-05	0.000255	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CD36—dilated cardiomyopathy	7.86e-05	0.000253	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CD36—dilated cardiomyopathy	7.71e-05	0.000248	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—RAC1—dilated cardiomyopathy	7.41e-05	0.000238	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—RAC1—dilated cardiomyopathy	7.27e-05	0.000234	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—EGFR—dilated cardiomyopathy	7.23e-05	0.000233	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.22e-05	0.000232	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.22e-05	0.000232	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.2e-05	0.000232	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EGFR—dilated cardiomyopathy	7.15e-05	0.00023	CbGpPWpGaD
Minocycline—IL1B—Immune System—ITGB1—dilated cardiomyopathy	7.12e-05	0.000229	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—RAF1—dilated cardiomyopathy	6.88e-05	0.000221	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.86e-05	0.000221	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.71e-05	0.000216	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GPX1—dilated cardiomyopathy	6.6e-05	0.000212	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.5e-05	0.000209	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CD36—dilated cardiomyopathy	6.43e-05	0.000207	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD36—dilated cardiomyopathy	6.07e-05	0.000195	CbGpPWpGaD
Minocycline—CASP1—Immune System—RAF1—dilated cardiomyopathy	6.07e-05	0.000195	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AGT—dilated cardiomyopathy	5.79e-05	0.000186	CbGpPWpGaD
Minocycline—IL1B—Immune System—RAC1—dilated cardiomyopathy	5.72e-05	0.000184	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—RAF1—dilated cardiomyopathy	5.66e-05	0.000182	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.64e-05	0.000181	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.55e-05	0.000178	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—EGFR—dilated cardiomyopathy	5.44e-05	0.000175	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.27e-05	0.000169	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.01e-05	0.000161	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.01e-05	0.000161	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—RAF1—dilated cardiomyopathy	4.91e-05	0.000158	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.9e-05	0.000157	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—RAF1—dilated cardiomyopathy	4.82e-05	0.000155	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—EGFR—dilated cardiomyopathy	4.72e-05	0.000152	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.66e-05	0.00015	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.52e-05	0.000145	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.51e-05	0.000145	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.45e-05	0.000143	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.35e-05	0.00014	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.35e-05	0.00014	CbGpPWpGaD
Minocycline—CASP1—Immune System—EGFR—dilated cardiomyopathy	4.16e-05	0.000134	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RAC1—dilated cardiomyopathy	4.09e-05	0.000131	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GPX1—dilated cardiomyopathy	4.07e-05	0.000131	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.04e-05	0.00013	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.04e-05	0.00013	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CD36—dilated cardiomyopathy	3.96e-05	0.000127	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.92e-05	0.000126	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGT—dilated cardiomyopathy	3.91e-05	0.000126	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EGFR—dilated cardiomyopathy	3.88e-05	0.000125	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.85e-05	0.000124	CbGpPWpGaD
Minocycline—IL1B—Immune System—RAF1—dilated cardiomyopathy	3.79e-05	0.000122	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—dilated cardiomyopathy	3.69e-05	0.000119	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.66e-05	0.000118	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AGT—dilated cardiomyopathy	3.57e-05	0.000115	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.39e-05	0.000109	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EGFR—dilated cardiomyopathy	3.37e-05	0.000108	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.34e-05	0.000108	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—dilated cardiomyopathy	3.21e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.17e-05	0.000102	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.14e-05	0.000101	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RAC1—dilated cardiomyopathy	2.84e-05	9.12e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.83e-05	9.1e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.73e-05	8.76e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGT—dilated cardiomyopathy	2.71e-05	8.72e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.71e-05	8.71e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—EGFR—dilated cardiomyopathy	2.6e-05	8.36e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RAC1—dilated cardiomyopathy	2.46e-05	7.92e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGT—dilated cardiomyopathy	2.35e-05	7.57e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RAF1—dilated cardiomyopathy	1.88e-05	6.05e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.86e-05	5.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RAF1—dilated cardiomyopathy	1.63e-05	5.25e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EGFR—dilated cardiomyopathy	1.29e-05	4.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EGFR—dilated cardiomyopathy	1.12e-05	3.6e-05	CbGpPWpGaD
